Isotype Diversification of IgG Antibodies to HIV Gag Proteins as a Therapeutic Vaccination Strategy for HIV Infection

The development of vaccines to treat and prevent human immunodeficiency virus (HIV) infection has been hampered by an incomplete understanding of “protective” immune responses against HIV. Natural control of HIV-1 infection is associated with T-cell responses against HIV-1 Gag proteins, particularly...

Descripción completa

Detalles Bibliográficos
Autores principales: French, Martyn A., Abudulai, Laila N., Fernandez, Sonia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494226/
https://www.ncbi.nlm.nih.gov/pubmed/26344116
http://dx.doi.org/10.3390/vaccines1030328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494226/
https://www.ncbi.nlm.nih.gov/pubmed/26344116
http://dx.doi.org/10.3390/vaccines1030328

Ejemplares similares